Literature DB >> 9174659

Genetic and biochemical analysis of TGF beta signal transduction.

R W Padgett1, C Savage, P Das.   

Abstract

TGF beta-like ligands are involved in many different developmental processes that pattern a variety of tissues in invertebrates and vertebrates. In the last few years, rapid progress has been made toward elucidating the developmental roles of the TGF beta-like pathways and identifying the novel components involved in transducing their signals, particularly the newly discovered Smads. This rapid progress has been the result of a synergy between classical genetic approaches and biochemical approaches, and this combined approach is likely to propel future understanding of the signaling pathway used by TGF beta.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174659     DOI: 10.1016/s1359-6101(96)00050-0

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  4 in total

1.  Characterization of a bone morphogenetic protein-responsive Smad-binding element.

Authors:  K Kusanagi; H Inoue; Y Ishidou; H K Mishima; M Kawabata; K Miyazono
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

2.  Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.

Authors:  Z A Quinn; C C Yang; J L Wrana; J C McDermott
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

3.  Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp.

Authors:  H Inoue; T Imamura; Y Ishidou; M Takase; Y Udagawa; Y Oka; K Tsuneizumi; T Tabata; K Miyazono; M Kawabata
Journal:  Mol Biol Cell       Date:  1998-08       Impact factor: 4.138

4.  A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.

Authors:  Jennifer L Sargent; Ausra Milano; Swati Bhattacharyya; John Varga; M Kari Connolly; Howard Y Chang; Michael L Whitfield
Journal:  J Invest Dermatol       Date:  2009-10-08       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.